Zevra Therapeutics (ZVRA) Cash from Investing Activities Growth (5y) (2019 - 2025)
Zevra Therapeutics (ZVRA) Cash from Investing Activities Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Zevra Therapeutics | 570.04 Mn | 369.43 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60.74% |
| Jun 30, 2025 | 395.39% |
| Mar 31, 2025 | 294.90% |
| Dec 31, 2024 | -305.34% |
| Sep 30, 2024 | -500.96% |
| Mar 31, 2024 | 35.46% |
| Dec 31, 2023 | 5.86% |
| Sep 30, 2023 | -150.82% |
| Jun 30, 2023 | 16.76% |
| Mar 31, 2023 | -31.30% |
| Dec 31, 2022 | -14.94% |
| Sep 30, 2022 | -45.50% |
| Jun 30, 2022 | -49.54% |
| Mar 31, 2022 | -21.75% |
| Dec 31, 2021 | -36.22% |
| Sep 30, 2021 | -14.88% |
| Jun 30, 2021 | 71.14% |
| Dec 31, 2020 | 73.27% |
| Jun 30, 2020 | 17.19% |
| Mar 31, 2020 | 12.13% |